vepafestinib   Click here for help

GtoPdb Ligand ID: 11678

Synonyms: example 85 [US20180009818A1]
Compound class: Synthetic organic
Comment: We obtained the chemical structure for vepafestinib from WHO Proposed list 125 of July 2021. This mapped to PubChem CID 134164132. The structure was first submitted to PubChem as an extraction from a Taiho Pharmaceutical patent [1]. Vepafestinib is claimed as a RET kinase inhibitor.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 107.53
Molecular weight 474.24
XLogP 2.41
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COCc1ccc(cc1)NC(=O)c1c(C#CCN2CCOCC2)n(c2c1c(N)ncn2)C1(C)CC1
Isomeric SMILES Nc1c2c(ncn1)n(c(c2C(=O)Nc1ccc(cc1)COC)C#CCN1CCOCC1)C1(CC1)C
InChI InChI=1S/C26H30N6O3/c1-26(9-10-26)32-20(4-3-11-31-12-14-35-15-13-31)21(22-23(27)28-17-29-24(22)32)25(33)30-19-7-5-18(6-8-19)16-34-2/h5-8,17H,9-16H2,1-2H3,(H,30,33)(H2,27,28,29)
InChI Key SFXVRNLGOSAWIV-UHFFFAOYSA-N
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
ret proto-oncogene Hs Inhibitor Inhibition 9.7 pIC50 - 1
pIC50 9.7 (IC50 2x10-10 M) [1]
Description: Inhibition of peptide substrate phosphorylation by recombinant human RET in the presence of test compound